Prestige Wealth Management Group LLC Purchases 960 Shares of CME Group Inc. (NASDAQ:CME)

Prestige Wealth Management Group LLC lifted its position in shares of CME Group Inc. (NASDAQ:CMEFree Report) by 87.8% during the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 2,053 shares of the financial services provider’s stock after purchasing an additional 960 shares during the quarter. Prestige Wealth Management Group LLC’s holdings in CME Group were worth $404,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of CME. Aveo Capital Partners LLC purchased a new stake in CME Group in the 4th quarter valued at $226,000. 9258 Wealth Management LLC boosted its stake in CME Group by 3.7% in the 4th quarter. 9258 Wealth Management LLC now owns 3,148 shares of the financial services provider’s stock worth $663,000 after purchasing an additional 113 shares during the period. Gryphon Financial Partners LLC purchased a new position in shares of CME Group during the 4th quarter valued at $547,000. Montag A & Associates Inc. grew its holdings in shares of CME Group by 26.5% during the fourth quarter. Montag A & Associates Inc. now owns 430 shares of the financial services provider’s stock worth $93,000 after purchasing an additional 90 shares in the last quarter. Finally, Principal Securities Inc. purchased a new stake in CME Group during the fourth quarter valued at about $742,000. 87.75% of the stock is currently owned by institutional investors.

Insiders Place Their Bets

In other news, Director Charles P. Carey sold 3,000 shares of the stock in a transaction dated Thursday, June 13th. The shares were sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now owns 7,163 shares of the company’s stock, valued at $1,399,936.72. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, Director Bryan T. Durkin sold 7,593 shares of the firm’s stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company’s stock, valued at approximately $11,932,706.13. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Charles P. Carey sold 3,000 shares of the business’s stock in a transaction dated Thursday, June 13th. The stock was sold at an average price of $195.44, for a total transaction of $586,320.00. Following the sale, the director now directly owns 7,163 shares in the company, valued at approximately $1,399,936.72. The disclosure for this sale can be found here. 0.30% of the stock is owned by insiders.

Wall Street Analyst Weigh In

CME has been the subject of several recent research reports. Barclays boosted their price objective on CME Group from $208.00 to $209.00 and gave the company an “equal weight” rating in a research report on Thursday, July 25th. Piper Sandler reiterated an “overweight” rating and set a $225.00 price target on shares of CME Group in a report on Tuesday, August 20th. JPMorgan Chase & Co. boosted their target price on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research note on Thursday, July 25th. Deutsche Bank Aktiengesellschaft increased their price objective on shares of CME Group from $193.00 to $200.00 and gave the stock a “hold” rating in a research note on Thursday, August 15th. Finally, Keefe, Bruyette & Woods boosted their price target on CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a report on Thursday, July 25th. Four analysts have rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $209.73.

Check Out Our Latest Research Report on CME

CME Group Stock Up 0.5 %

Shares of CME traded up $1.12 during midday trading on Friday, reaching $220.50. 2,899,331 shares of the stock were exchanged, compared to its average volume of 1,933,394. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $223.80. The company’s 50 day moving average is $203.51 and its two-hundred day moving average is $207.59. The company has a market capitalization of $79.39 billion, a P/E ratio of 25.09, a PEG ratio of 6.51 and a beta of 0.55. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last issued its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. During the same quarter in the prior year, the firm earned $2.30 earnings per share. CME Group’s revenue for the quarter was up 12.7% on a year-over-year basis. On average, sell-side analysts anticipate that CME Group Inc. will post 9.89 earnings per share for the current year.

CME Group Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Monday, September 9th will be given a dividend of $1.15 per share. The ex-dividend date of this dividend is Monday, September 9th. This represents a $4.60 dividend on an annualized basis and a yield of 2.09%. CME Group’s payout ratio is presently 52.33%.

CME Group Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.